Business Context and Reporting Period
Company: Canopy Growth Corp (CGC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2024 (First Quarter of Fiscal 2025)
Reporting Currency: Canadian Dollars (CDN$)
Canopy Growth is a global cannabis company with core operations in Canada, Europe, and Australia. The quarter was defined by significant strategic restructuring, including the deconsolidation of its U.S. holding company, Canopy USA, effective April 30, 2024, to comply with Nasdaq listing requirements. The company also completed the divestiture of its "This Works" consumer products segment in the prior fiscal year, resulting in zero revenue from that segment in the current period.
Key Financial Metrics
| Metric (CDN$ in thousands) | Q1 2025 (Ended June 30, 2024) | Q1 2024 (Ended June 30, 2023) |
|---|---|---|
| Net Revenue | $66,212 | $76,258 |
| Gross Margin | $23,031 | $13,762 |
| Gross Margin % | 35% | 18% |
| Operating Loss | $(29,108) | $(54,652) |
| Net Loss (Continuing Ops) | $(129,191) | $(10,569) |
| Net Loss (Total) | $(127,138) | $(41,861) |
| Cash & Equivalents | $192,156 | $533,266 |
| Total Debt (Principal) | $584,500 | $622,000 |
| Free Cash Flow | $(55,700) | $(108,165) |
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 13% year-over-year to $66.2 million. This was driven by the absence of "This Works" revenue ($6.0M in prior year) and a 22% decline in Canadian adult-use cannabis sales due to supply constraints and price competition. Conversely, Canadian medical cannabis revenue grew 20%.
- Margin Expansion: Gross margin percentage improved significantly from 18% to 35%. This was primarily due to cost savings initiatives, reduced inventory write-downs, and a shift toward higher-margin medical sales in Canada.
- Net Loss Widening: The net loss from continuing operations widened to $129.2 million from $10.6 million. This deterioration was driven by a $140 million swing in "Other income (expense), net," largely due to a $76 million non-cash fair value loss on the Canopy USA equity method investment and a $31.8 million fair value decrease in the Acreage financial instrument.
- Deconsolidation of Canopy USA: Effective April 30, 2024, Canopy USA was deconsolidated. The company now accounts for its interest in Canopy USA (which holds U.S. assets like Wana, Jetty, and Acreage) as an equity method investment valued at $150.7 million.
Guidance, Outlook, and Risks
- Liquidity and Going Concern: Management states that substantial doubt regarding the company's ability to continue as a going concern has been alleviated. This follows successful debt refinancing, the exchange of the Constellation Brands (CBI) promissory note into exchangeable shares, and the establishment of an At-The-Market (ATM) equity program.
- Debt Restructuring: The company executed a $100 million CBI note exchange and issued a new $96.4 million convertible debenture. A mandatory prepayment of $97.5 million on the Credit Facility is required by December 31, 2024, with a maturity extension to December 2026.
- Strategic Outlook: The company is focused on executing its U.S. strategy through Canopy USA, pending the closing of the Acreage acquisition. The Acreage acquisition is subject to conditions, including Acreage's ability to maintain going concern status.
- Risks:
- Acreage Going Concern: Acreage's financial statements express doubt about its ability to continue as a going concern, which could jeopardize the acquisition.
- Regulatory/Legal: Ongoing SEC investigation regarding the BioSteel revenue restatement and various shareholder class actions (though one U.S. securities class action was dismissed with prejudice in July 2024).
- Market Conditions: Continued price competition in the Canadian adult-use market and supply chain constraints.
Investor Verification Checklist
- Debt Covenants: Verify the company's ability to meet the mandatory $97.5 million Credit Facility prepayment due December 31, 2024, and the liquidity requirements of the Amended Credit Agreement.
- Acreage Acquisition Status: Monitor the satisfaction of closing conditions for the Acreage acquisition, specifically Acreage's financial stability and regulatory approvals.
- Canopy USA Valuation: Review the fair value assumptions used for the Canopy USA equity method investment, as volatility in this asset significantly impacts reported net income.
- Legal Proceedings: Track the status of the SEC investigation into BioSteel and the potential for appeals regarding the dismissed U.S. securities class action.
- ATM Program Utilization: Monitor the pace of share issuance under the ATM program and its impact on shareholder dilution versus liquidity generation.